Second study shows that octreotide may prevent early rebleeding in cirrhosis

BMJ. 1998 Apr 25;316(7140):1320. doi: 10.1136/bmj.316.7140.1320.
No abstract available

Publication types

  • Clinical Trial
  • Comment
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use*
  • Double-Blind Method
  • Esophageal and Gastric Varices / drug therapy*
  • Gastrointestinal Agents / therapeutic use*
  • Gastrointestinal Hemorrhage / prevention & control*
  • Humans
  • Liver Cirrhosis / complications
  • Octreotide / therapeutic use*
  • Recurrence
  • Sclerotherapy / methods

Substances

  • Adrenergic beta-Antagonists
  • Gastrointestinal Agents
  • Octreotide